How Do Coronary Lipid-Rich Plaques Change After Cessation of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors?　― Serial Assessment Using Near-Infrared Spectroscopy ―

Hiroyuki Omori; Hideaki Ota; Takuya Mizukami; Yoshiaki Kawase; Toru Tanigaki; Tetsuo Hirata; Munenori Okubo; Masanori Kawasaki; Hitoshi Matsuo

doi:10.1253/circj.CJ-21-0211

Images in Cardiovascular Medicine

How Do Coronary Lipid-Rich Plaques Change After Cessation of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors?　― Serial Assessment Using Near-Infrared Spectroscopy ―

Hiroyuki Omori, Hideaki Ota, Takuya Mizukami, Yoshiaki Kawase, Toru Tanigaki, Tetsuo Hirata, Munenori Okubo, Masanori Kawasaki, Hitoshi Matsuo

Author information

Hiroyuki Omori
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Hideaki Ota
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Takuya Mizukami
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University [Japan]
Yoshiaki Kawase
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Toru Tanigaki
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Tetsuo Hirata
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Munenori Okubo
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Masanori Kawasaki
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]
Hitoshi Matsuo
Department of Cardiovascular Medicine, Gifu Heart Center [Japan]

JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2021 Volume 85 Issue 8 Pages 1404-

DOI https://doi.org/10.1253/circj.CJ-21-0211

Browse “Advance online publication” version

Details

Corresponding author

Register with J-STAGE for free!